Feinstein Institute Presents Inaugural Ross Prize
Dr. Dan R. Littman will receive the inaugural Ross Prize in Molecular Medicine for his contributions to the fields of immunology and virology.
Published June 14, 2013
By Diana Friedman
On Monday, June 24, the New York Academy of Sciences will host Translating Immunology Discoveries into Therapies: Inaugural Ross Prize in Molecular Medicine. Renowned immunologist Dan R. Littman, MD, PhD, will receive the inaugural Ross Prize in Molecular Medicine for his early discoveries and ongoing research to better understand viral, immune, and inflammatory diseases. The Ross Prize was established by the Feinstein Institute for Medical Research and Molecular Medicine.
“The Ross Prize in Molecular Medicine was conceived to recognize scientific advances and to honor people whose discoveries change the way medicine is practiced,” says Kevin J. Tracey, MD, president of the Feinstein Institute.
Innovative, Paradigm-Shifting Research
According to the prize committee, Dr. Littman is an active investigator who produces innovative, paradigm-shifting research that is worthy of significant and broad attention in the field of molecular medicine.
“It is a great honor for me to receive this prize, as it recognizes the importance of basic research in creating opportunities to advance our understanding of immune system-related diseases, which have a very large impact on our society,” says Dr. Littman. “There is growing consensus that inflammatory processes have central roles in diseases that affect many physiological processes, and I thank the Feinstein Institute and Molecular Medicine for recognizing this exciting area of research.”
In addition to a special talk by Dr. Littman, leading scientists in immunology will discuss new insights in the mechanism of immune system function and signaling that provide clues to the prevention or treatment of autoimmune and inflammatory diseases. Yasmine Belkaid, PhD, National Institute of Allergy and Infectious Diseases, NIH, and Alexander Rudensky, PhD, Memorial Sloan-Kettering Cancer Center, will each deliver a scientific presentation.
Also read: Advancing Medical Research: From T Cells to Therapies
